Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page
- ChecktodayChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1 on a 403 Forbidden error page.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content and signaling restricted access to the study page.SummaryDifference17%

- Check42 days agoChange DetectedThe status text changed from 'No Results Posted' to 'Results Submitted', indicating that results data have been submitted for the trial and are moving toward public posting.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6. This reflects a backend/UI software update and does not change study content or data on the page.SummaryDifference0.1%

- Check70 days agoChange DetectedFooter revision updated from v3.6.4 to v3.6.5. This indicates a minor site update and does not affect the study information.SummaryDifference0.1%

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.